Fintel reports that on October 14, 2024, Redburn Atlantic initiated coverage of Thermo Fisher Scientific (LSE:0R0H) with a Buy recommendation.
Analyst Price Forecast Suggests 10.62% Upside
As of September 25, 2024, the average one-year price target for Thermo Fisher Scientific is 661.21 GBX/share. The forecasts range from a low of 570.25 GBX to a high of 804.78 GBX. The average price target represents an increase of 10.62% from its latest reported closing price of 597.75 GBX / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Thermo Fisher Scientific is 49,548MM, an increase of 17.01%. The projected annual non-GAAP EPS is 27.01.
What is the Fund Sentiment?
There are 3,883 funds or institutions reporting positions in Thermo Fisher Scientific. This is an increase of 59 owner(s) or 1.54% in the last quarter. Average portfolio weight of all funds dedicated to 0R0H is 0.67%, an increase of 6.81%. Total shares owned by institutions increased in the last three months by 4.94% to 385,277K shares.
What are Other Shareholders Doing?
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 12,062K shares representing 3.16% ownership of the company. In its prior filing, the firm reported owning 11,987K shares , representing an increase of 0.62%. The firm decreased its portfolio allocation in 0R0H by 6.90% over the last quarter.
Price T Rowe Associates holds 9,925K shares representing 2.60% ownership of the company. In its prior filing, the firm reported owning 10,055K shares , representing a decrease of 1.30%. The firm decreased its portfolio allocation in 0R0H by 8.30% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 9,797K shares representing 2.56% ownership of the company. In its prior filing, the firm reported owning 9,737K shares , representing an increase of 0.62%. The firm decreased its portfolio allocation in 0R0H by 9.37% over the last quarter.
Capital World Investors holds 9,518K shares representing 2.49% ownership of the company. In its prior filing, the firm reported owning 13,494K shares , representing a decrease of 41.77%. The firm decreased its portfolio allocation in 0R0H by 33.87% over the last quarter.
Capital Research Global Investors holds 8,237K shares representing 2.16% ownership of the company. In its prior filing, the firm reported owning 8,113K shares , representing an increase of 1.51%. The firm decreased its portfolio allocation in 0R0H by 6.31% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
